Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content inl-Thyroxine in the Outcome of Ablation-Reference-Cited by-同舟云学术

Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content inl-Thyroxine in the Outcome of Ablation

Published:2003-09 Issue:9 Volume:88 Page:4110-4115
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Barbaro Daniele,Boni Giuseppe,Meucci Giuseppe,Simi Umberto,Lapi Paola,Orsini Paola,Pasquini Cristina,Piazza Francesca,Caciagli Marco,Mariani Giuliano

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies;European Journal of Endocrinology;2023-01-19

2. The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules;Scientific Reports;2022-08-17

3. Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer;Diagnostics;2022-07-21

4. Radioiodine Ablation for Thyroid Cancer. Historical and Modern Aspects. Literature Review;Journal of oncology: diagnostic radiology and radiotherapy;2021-11-26

5. Influence of Levothyroxine With Recombinant Human Thyroid-Stimulating Hormone on Urinary Iodine Excretion Before Radioactive Iodine Administration;Endocrine Practice;2021-10